Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FE6H5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,038
Award facts
- Contract value 100% obligated
- $23,037.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,037.56 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Wegovy 1 mg/0.5 mL pens. This is a firm fixed-price delivery order with no set-aside designation, demonstrating that the award was competitively made under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive IDC to supply a broad spectrum of pharmaceutical products and medical supplies to support Defense Health Agency operations and other government healthcare entities worldwide. The company's significant contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill complex federal medical procurement requirements across multiple therapeutic domains, from specialty medications to vaccines and medical devices. This particular delivery order for Wegovy, a GLP-1 receptor agonist medication, reflects the federal healthcare system's procurement of modern pharmaceutical treatments for beneficiary populations.
Quick answers
Who was awarded contract SPE2DB25FE6H5?
SPE2DB25FE6H5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FE6H5 worth?
The government has obligated $23,038 on SPE2DB25FE6H5.
Is contract SPE2DB25FE6H5 an order under another contract?
Yes. SPE2DB25FE6H5 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE6H5 competed?
The extent of competition for SPE2DB25FE6H5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award